CO-IRBEK®

CO-IRBEK® is an antihypertensive angiotensin receptor antagonist (ARA II), indicated in the treatment of essential hypertension, also in renal impairment in hypertensive patients with type 2 diabetes.

Additional information

DCI

IRBESARTAN / HCTZ

Dosage

300/25 mg

Trade name

CO-IRBEK®

Name of the originator

Co Aprovel

Presentation

30 tablets

Specialty

Cardiologie – Sartans

See also